特发性肺纤维化与肺癌的共同致病机制
The Co-Pathogenesis of Idiopathic Pulmonary Fibrosis and Lung Cancer
DOI: 10.12677/ACM.2022.125676, PDF,   
作者: 山春玲：青海大学，青海 西宁；拉周措毛：青海大学附属医院呼吸科，青海 西宁
关键词: 特发性肺纤维化；肺癌；发病机制；Idiopathic Pulmonary Fibrosis； Lung Cancer； Pathogenesis
摘要: 在特发性肺纤维化(idiopathic pulmonary fibrosis, IPF)病程进展中，患者并发肺癌的概率明显偏高，且严重威胁患者生命健康，而IPF合并肺癌在肿瘤表现、临床诊断和治疗方面均有不同于单纯肺癌患者的特点。大量的流行病学证据支持IPF和肺癌之间的联系。对IPF和肺癌患者的最佳管理需要了解这两种疾病共同的致病机制和分子途径。本文综述了目前关于肺纤维化发病机制的研究现状，并通过其分子机制总结了IPF和肺癌的共同通路。
Abstract: In the progression of idiopathic pulmonary fibrosis (IPF), the probability of patients with lung can-cer is significantly higher, and seriously threatens the life and health of patients, while IPF with lung cancer has characteristics different from those of patients with lung cancer alone in tumor manifes-tations, clinical diagnosis and treatment. Substantial epidemiological evidence supports an associa-tion between IPF and lung cancer. Optimal management of patients with IPF and lung cancer re-quires an understanding of the common pathogenic mechanisms and molecular pathways of both diseases. This paper reviews the current research on the pathogenesis of pulmonary fibrosis, and summarizes the common pathway of IPF and lung cancer through its molecular mechanism.
文章引用：山春玲, 拉周措毛. 特发性肺纤维化与肺癌的共同致病机制[J]. 临床医学进展, 2022, 12(5): 4674-4679. https://doi.org/10.12677/ACM.2022.125676

参考文献

[1] Selman, M., King, T.E. and Pardo, A. (2001) Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy. Annals of Internal Medicine, 134, 136-151. [Google Scholar] [CrossRef] [PubMed]
[2] 沈梦君, 曹卫军. 伴肺癌的特发性肺纤维化22例临床分析[J]. 国际呼吸志, 2018, 38(8): 584-589.
[3] 张楠, 雷伟, 曾辉, 黄建安. 特发性肺纤维化合并肺癌37例临床分析[J]. 实用癌症杂志, 2016, 31(9): 1473- 1475+41479.
[4] Betensley, A., Sharif, R. and Karamichos, D. (2016) A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idio-pathic Pulmonary Fibrosis. Journal of Clinical Medicine, 6, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
[5] Grimminger, F., Gunther, A. and Vancheri, C. (2015) The Role of Tyro-sine Kinases in the Pathogenesis of Idiopathic Pulmonary Fibrosis. European Respiratory Journal, 45, 1426-1433. [Google Scholar] [CrossRef] [PubMed]
[6] Liu, J.Y., Morris, G.F., Lei, W.H., Hart, C.E., Lasky, J.A. and Brody, A.R. (1997) Rapid Activation of PDGF-A and -B Expression at Sites of Lung Injury in Asbestos-Exposed Rats. American Journal of Respiratory Cell and Molecular Biology, 17, 129-140. [Google Scholar] [CrossRef] [PubMed]
[7] Inoue, Y., King Jr., T.E., Tinkle, S.S., Dockstader, K. and Newman, L.S. (1996) Human Mast Cell Basic Fibroblast Growth Factor in Pulmonary Fibrotic Disorders. The American Journal of Pathology, 149, 2037-2054.
[8] Madtes, D.K., Busby, H.K., Strandjord, T.P. and Clark, J.G. (1994) Expression of Transforming Growth Factor-Alpha and Epidermal Growth Factor Receptor Is Increased Following Bleomycin-Induced Lung Injury in Rats. American Journal of Respiratory Cell and Molecular Biology, 11, 540-551. [Google Scholar] [CrossRef] [PubMed]
[9] Korfhagen, T.R., Swantz, R.J., Wert, S.E., McCarty, J.M., Ker-lakian, C.B., Glasser, S.W. and Whitsett, J.A. (1994) Respiratory Epithelial Cell Expression of Human Transforming Growth Factor-Alpha Induces Lung Fibrosis in Transgenic mice. Journal of Clinical Investigation, 93, 1691-1699. [Google Scholar] [CrossRef] 
[10] Sugahara, K., Iyama, K., Kuroda, M.J. and Sano, K. (1998) Double In-tratracheal Instillation of Keratinocyte Growth Factor Prevents Bleomycin-Induced Lung Fibrosis in Rats. The Journal of Pathology, 186, 90-98. [Google Scholar] [CrossRef] 
[11] Maeda, J., Ueki, N., Hada, T. and Higashino, K. (1995) Elevated Serum Hepatocyte Growth Factor/Scatter Factor Levels in Inflammatory Lung Disease. American Journal of Respiratory and Critical Care Medicine, 152, 1587-1591. [Google Scholar] [CrossRef] [PubMed]
[12] Hinz, B. (2012) Mechanical Aspects of Lung Fibrosis: A Spot-light on the Myofibroblast. Proceedings of the American Thoracic Society, 9, 137-147. [Google Scholar] [CrossRef] 
[13] Rabinovich, E.I., Kapetanaki, M.G., Steinfeld, I., Gibson, K.F., Pandit, K.V., Yu, G., Yakhini, Z. and Kaminski, N. (2012) Global Methylation Patterns in Idiopathic Pulmonary Fibrosis. PLoS ONE, 7, Article ID: e33770. [Google Scholar] [CrossRef] [PubMed]
[14] Baumgartner, K.B., Samet, J.M., Stidley, C.A., Colby, T.V. and Waldron, J.A. (1997) Cigarette Smoking: A Risk Factor for Idiopathic Pulmonary Fibrosis. American Journal of Respir-atory and Critical Care Medicine, 155, 242-248. [Google Scholar] [CrossRef] [PubMed]
[15] Turner-Warwick, M., Lebowitz, M., Burrows, B. and Johnson, A. (1980) Cryptogenic Fibrosing Alveolitis and Lung Cancer. Thorax, 35, 496-499. [Google Scholar] [CrossRef] [PubMed]
[16] Hojo, S., Fujita, J., Yamadori, I., Kamei, T., Yoshinouchi, T., Ohtsuki, Y., Okada, H., Bandoh, S., Yamaji, Y., Takahara, J., et al. (1998) Heterogeneous Point Mutations of the p53 Gene in Pul-monary Fibrosis. European Respiratory Journal, 12, 1404-1408. [Google Scholar] [CrossRef] [PubMed]
[17] Richeldi, L., Costabel, U., Selman, M., Kim, D.S., Hansell, D.M., Nicholson, A.G., et al. (2011) Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. The New England Journal of Medicine, 265, 1079-1087. [Google Scholar] [CrossRef] [PubMed]
[18] Drakopanagiotakis, F., Xifteri, A., Polychronopoulos, V. and Bouros, D. (2008) Apoptosis in Lung Injury and Fibrosis. European Respiratory Journal, 32, 1631-1638. [Google Scholar] [CrossRef] [PubMed]
[19] Khan, K.A., Kennedy, M.P., Moore, E., Crush, L., Prendeville, S., Maher, M.M., et al. (2015) Radiological Characteristics, Histological Features and Clinical Outcomes of Lung Cancer Patients with Coexistent Idiopathic Pulmonary Fibrosis. Lung, 193, 71-77. [Google Scholar] [CrossRef] [PubMed]
[20] Vancheri, C. (2015) Idiopathic Pulmonary Fibrosis and Cancer: Do They Really Look Similar? BMC Medicine, 13, Article No. 220. [Google Scholar] [CrossRef] [PubMed]
[21] Nathan, N., Giraud, V., Picard, C., Crush, L., Nunes, H., Dastot-Le Moal, F., Copin, B., et al. (2016) Germline SFTPA1 Mutation in Familial Idiopathic Interstitial Pneumonia and Lung Cancer. Human Molecular Genetics, 25, 1457-1467. [Google Scholar] [CrossRef] [PubMed]
[22] Losa, D., Chanson, M. and Crespin, S. (2011) Connexins as Therapeu-tic Targets in Lung Disease. Expert Opinion on Therapeutic Targets, 15, 989-1002. [Google Scholar] [CrossRef] [PubMed]
[23] Grimminger, F., Schermuly, R.T. and Ghofrani, H.A. (2010) Targeting Non-Malignant Disorders with Tyrosine Kinase Inhibitors. Nature Reviews Drug Discovery, 9, 956-970. [Google Scholar] [CrossRef] [PubMed]
[24] Desmouliere, A., Guyot, C. and Gabbiani, G. (2004) The Stroma Reaction Myofibroblast: A Key Player in the Control of Tumor Cell Behavior. The International Journal of Developmental Biolo-gy, 48, 509-517. [Google Scholar] [CrossRef] [PubMed]
[25] Chilosi, M., Zamo, A., Doglioni, C., Reghellin, D., Lestani, M., Mon-tagna, L., Pedron, S., Ennas, M.G., Cancellieri, A., Murer, B., et al. (2006) Migratory Marker Expression in Fibroblast Foci of Idiopathic Pulmonary Fibrosis. Respiratory Research, 7, Article No. 95. [Google Scholar] [CrossRef] [PubMed]
[26] Kidera, Y., Tsubaki, M., Yamazoe, Y., Shoji, K., Nakamura, H., Ogaki, M., Satou, T., Itoh, T., Isozaki, M., Kaneko, J., et al. (2010) Reduction of Lung Metastasis, Cell Invasion, and Adhesion in Mouse Melanoma by Statin-Induced Blockade of the Rho/Rho-Associated Coiled-Coil-Containing Protein Kinase Pathway. Journal of Experimental & Clinical Cancer Research, 29, Article No. 127. [Google Scholar] [CrossRef] [PubMed]
[27] Mills, C.D., Lenz, L.L. and Harris, R.A. (2016) A Breakthrough: Macrophage-Directed Cancer Immunotherapy. Cancer Research, 76, 513-516. [Google Scholar] [CrossRef] 

为你推荐